A cross‐sectional study of outcomes for patients undergoing mechanical thrombectomy for pulmonary embolism during 2018–2022: Insights from the PINC AI Healthcare Database

Abstract

AbstractBackground and AimsMechanical thrombectomy (MT) treatments for pulmonary embolism (PE) have yet to be compared directly. We aimed to determine if patient outcomes varied following treatment of PE with different MT devices.MethodsAll PE encounters with an index treatment of MT between January 2018 and March 2022 were analyzed for in‐hospital mortality, discharge to home, and 30‐day readmission outcomes in the PINC AI™ Healthcare Database. MT devices used in each encounter were extracted from hospital charge description free‐text fields using keyword text and fuzzy matching. Unadjusted and adjusted logistic regression was used to model outcomes by device.ResultsA total of 5893 encounters were identified using MT as the sole index PE treatment and 1812 using MT with another treatment. Of these, 41% had insufficient information to identify the devices used (unspecified MT), 33% used the FlowTriever System (large‐bore volume‐controlled aspiration MT), 23% the Indigo System (continuous aspiration MT), and 3% some other MT. Large‐bore volume‐controlled aspiration MT was used with other treatments 13% of the time compared with 23% and 39% for unspecified MT and continuous aspiration MT, respectively. Adjusted logistic regression modeling revealed the odds of in‐hospital mortality were significantly higher for patients treated with unspecified MT ([OR] = 1.42, 95% confidence interval [CI]: [1.10–1.83], p = 0.008) or continuous aspiration MT (OR = 1.63, 95% CI: [1.21–2.19], p = 0.001) compared with large‐bore volume‐controlled aspiration MT. Discharge to home was significantly lower in these same groups (OR = 0.84, 95% CI: [0.73–0.96], p = 0.01, and OR = 0.63, 95% CI: [0.53–0.74], p < 0.001, respectively), but readmission risks at 30 days were comparable (OR = 1.08, 95% CI: [0.84–1.38], p = 0.56, and OR = 1.20, 95% CI: [0.89–1.62], p = 0.24, respectively).ConclusionPE outcomes and treatment patterns differ significantly based on the type of MT utilized. Clinical studies directly comparing MT treatments are needed to further understand optimal treatment of PE.